Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
03/03/1998 | US5723313 ARF-p19, a novel regulator of the mammalian cell cycle |
03/03/1998 | US5723312 Derived from insect triatoma; anticoagulants; antitumor, anticarcinogenic, and antimetastasis agents; genetic engineering |
03/03/1998 | US5723311 Human DNA topoisomerase I α |
03/03/1998 | US5723309 Production of subunits of soluble T cell receptors by co-transfection |
03/03/1998 | US5723129 GnRH-leukotoxin chimeras |
03/03/1998 | US5723128 Cytotoxic T-cell lymphocyte ("CTL") activity regulation by class I MHC peptides |
03/03/1998 | US5723127 Cancer therapy, vaccines; cell-mediated immune response enhancers |
03/03/1998 | US5723126 Methods and compositions for therapeutic uses of a fibrin-specific monoclonal antibody |
03/03/1998 | US5723125 Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide |
03/03/1998 | US5723123 Process for the production of a virus-free concentrate of thrombin |
03/03/1998 | US5723122 Use of the protease domain of human plasminogen activator for the treatment of thromboembolic diseases |
03/03/1998 | US5723121 Sugar modified interferon |
03/03/1998 | US5723120 Method of treating an IL-6 related disease with interleukin-6 receptor antagonists |
03/03/1998 | US5723119 Method for enhancing wound healing/repair with IL-4 |
03/03/1998 | US5723118 Therapeutic agents which are antagonists or partial agonists of human interleukin 4 |
03/03/1998 | US5723117 Use of interleukin-1 (IL-1) to inhibit development of hepatitis |
03/03/1998 | US5723116 Decreased mortality of severe acute pancreatitis following proximal cytokine blockade |
03/03/1998 | US5723115 Inhibition of adipose tissue development and obesity |
03/03/1998 | US5722428 Diapase, vision defects |
03/03/1998 | CA1339694C Human high-affinity neurotranmitter uptake system |
02/28/1998 | CA2212954A1 Pharmaceutical composition for prophylaxis and/or treatment of apoptosis-related diseases |
02/26/1998 | WO1998007886A1 Process for identification of genes encoding proteins having cell proliferation-promoting activity |
02/26/1998 | WO1998007881A1 T1 receptor-like ligand i |
02/26/1998 | WO1998007880A1 Human endokine alpha |
02/26/1998 | WO1998007878A2 Long-term expression of gene products by transforming muscle cells |
02/26/1998 | WO1998007877A1 A short-shafted adenoviral fiber and its use |
02/26/1998 | WO1998007876A2 Self-replicating episomal expression vectors conferring tissue-specific gene expression |
02/26/1998 | WO1998007872A1 Homocysteine desulphurase from the protozoan trichomonas vaginalis |
02/26/1998 | WO1998007870A1 Novel raftk signaling molecules and uses therefor |
02/26/1998 | WO1998007865A1 Targeting adenovirus with use of constrained peptide motifs |
02/26/1998 | WO1998007864A1 Recombinant toxin fragments |
02/26/1998 | WO1998007863A1 HUMAN INTERFERON τ VARIANTS |
02/26/1998 | WO1998007862A2 Chemokine beta-16 |
02/26/1998 | WO1998007860A1 HUMAN POLYHOMEOTIC 1 (hph1) ACTS AS AN ONCOGENE |
02/26/1998 | WO1998007859A2 Secreted proteins and polynucleotides encoding them |
02/26/1998 | WO1998007858A1 HUMAN POLYHOMEOTIC 1(hphl) ACTS AS A TUMOR SUPPRESSOR |
02/26/1998 | WO1998007855A2 Secreted proteins and polynucleotides encoding them |
02/26/1998 | WO1998007854A1 Human glycine transporter |
02/26/1998 | WO1998007853A1 Secreted proteins and polynucleotides encoding them |
02/26/1998 | WO1998007851A2 Agents for the pre-symptomatic detection, prevention and treatment of breast cancer in humans |
02/26/1998 | WO1998007850A2 Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease and down syndrome in humans |
02/26/1998 | WO1998007849A1 Madr2 tumour suppressor gene |
02/26/1998 | WO1998007841A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
02/26/1998 | WO1998007840A1 Novel dnas and process for producing proteins by using the same |
02/26/1998 | WO1998007838A1 Higher animal telomerase protein and gene encoding the same |
02/26/1998 | WO1998007833A1 Compositions and methods for use of defensin |
02/26/1998 | WO1998007832A1 Recombinant vascular endothelial cell growth factor d (vegf-d) |
02/26/1998 | WO1998007754A1 T1 receptor-like ligand ii |
02/26/1998 | WO1998007752A1 Self-assembling amphiphiles for construction of peptide secondary structures |
02/26/1998 | WO1998007751A1 A process for purifying apolipoprotein a or apolipoprotein e from human plasma |
02/26/1998 | WO1998007750A1 Novel osteopontin derived chemotactic peptides and methods of use |
02/26/1998 | WO1998007749A1 Novel human growth factors |
02/26/1998 | WO1998007746A1 B1-bradykinin receptor antagonists and use thereof |
02/26/1998 | WO1998007745A2 Compositions and methods for treating infections using analogues of indolicidin |
02/26/1998 | WO1998007744A1 Synthetic peptides and their use in cosmetic or dermopharmaceutical compositions |
02/26/1998 | WO1998007743A1 Macrolides |
02/26/1998 | WO1998007738A1 Immunoglobulin trans-spliced transcripts and uses thereof |
02/26/1998 | WO1998007736A1 Don-1 gene and polypeptides and uses therefor |
02/26/1998 | WO1998007735A1 Pancreas-derived plasminogen activator inhibitor |
02/26/1998 | WO1998007696A1 Stable non-hygroscopic crystalline form of n-[n-n-(4-(piperidin-4-yl)butanoyl)-n-ethylglycyl] compounds |
02/26/1998 | WO1998007446A1 Protein formulations |
02/26/1998 | WO1998007444A1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION |
02/26/1998 | WO1998007442A1 Sustained-release preparation comprising erythropoietin and polylactide coglycolide |
02/26/1998 | WO1998007441A1 Allogeneic histocompatibility complexes as mediators of cell destruction |
02/26/1998 | WO1998007440A1 A novel antimicrobial peptide isolated from bufo bufo gargarizans |
02/26/1998 | WO1998007438A1 Compositions and methods for skin tanning and protection |
02/26/1998 | WO1998007435A1 Eye treatments using synthetic thyroid hormone compositions |
02/26/1998 | WO1998007415A2 Methods for prevention of cellular proliferation and restenosis |
02/26/1998 | WO1998007320A1 NEUTRALIZATION-SENSITIVE EPITOPES OF $i(CRYPTOSPORIDIUM PARVUM) |
02/26/1998 | WO1998007308A2 Thrombin inhibitors |
02/26/1998 | WO1998003652A3 P300/cbp-associated transcriptional co-factor p/caf and uses thereof |
02/26/1998 | WO1998002546A3 Dna immunization against chlamydia infection |
02/26/1998 | WO1998002453A3 Peptidic ligands having a higher selectivity for the vip1 receptor than for the vip2 receptor |
02/26/1998 | WO1997049818A3 G-beta-gamma regulated phosphatidylinositol-3' kinase |
02/26/1998 | WO1997049807A3 A novel hypertension related calcium regulated gene (hcarg) |
02/26/1998 | WO1997049373A3 Treatment and prevention of hiv infection by administration of derivatives of human chorionic gonadotropin |
02/26/1998 | WO1997046681A3 Galanin receptor galr2 |
02/26/1998 | WO1997039123A3 Secreted proteins |
02/26/1998 | WO1997022621A3 Antineoplastic peptides |
02/26/1998 | DE19649207C1 Nucleic acid characteristic of late or early passage cells immortalised by papilloma virus |
02/26/1998 | DE19648962C1 DNA encoding peptide(s) from papilloma virus major capsid protein |
02/26/1998 | CA2269654A1 Long-term expression of gene products by transforming muscle cells |
02/26/1998 | CA2264203A1 Compositions and methods for use of defensin |
02/26/1998 | CA2264200A1 Human endokine alpha |
02/26/1998 | CA2264192A1 Secreted proteins and polynucleotides encoding them |
02/26/1998 | CA2263942A1 Novel osteopontin derived chemotactic peptides and methods of use |
02/26/1998 | CA2263894A1 Novel human growth factors |
02/26/1998 | CA2263890A1 Recombinant vascular endothelial cell growth factor d (vegf-d) |
02/26/1998 | CA2263875A1 Secreted proteins and polynucleotides encoding them |
02/26/1998 | CA2263871A1 Allogeneic histocompatibility complexes as mediators of cell destruction |
02/26/1998 | CA2263854A1 Don-1 gene and polypeptides and uses therefor |
02/26/1998 | CA2263832A1 T1 receptor-like ligand ii |
02/26/1998 | CA2263830A1 T1 receptor-like ligand i |
02/26/1998 | CA2263799A1 Compositions and methods for treating infections using analogues of indolicidin |
02/26/1998 | CA2263796A1 Self-replicating episomal expression vectors conferring tissue-specific gene expression |
02/26/1998 | CA2263744A1 Process for identification of genes encoding proteins having cell proliferation-promoting activity |
02/26/1998 | CA2263192A1 Secreted proteins and polynucleotides encoding them |
02/26/1998 | CA2263189A1 A short-shafted adenoviral fiber and its use |
02/26/1998 | CA2263141A1 Neutralization-sensitive epitopes of cryptosporidium parvum |
02/26/1998 | CA2263140A1 Targeting adenovirus with use of constrained peptide motifs |